http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2627437-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L12-143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L12-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N57-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-6615 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L12-14 |
| filingDate | 2008-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d60515073bf789811ecb21abe619d1d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61393a67ecde5e99384f9137c1bd3ad3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d938c02adc2464f62f5b4a6155c48c47 |
| publicationDate | 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2627437-T3 |
| titleOfInvention | Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions |
| abstract | Sterile pharmaceutical composition comprising an effective preservative amount of a compound of the following formula, ** Formula ** in which: R1 and R3 are (C1-C6) alkyl; R2 is selected from the group consisting of hydrogen and (C1-C16) alkyl optionally substituted with NHC (> = O) - (CH2) 10CH3 or NHC (> = OHCH2) 12CH3; R4 is selected from the group consisting of hydrogen and CH2CH (Y) CH2N + R1R2R3X, in which R1, R2, and R3, are as defined above; X is halo; Y is selected from the group consisting of OH, O-C1-C10 alkyl and O-alkenyl (C1-C10); M is selected from the group consisting of sodium and potassium; a physiologically suitable buffer, and a pharmaceutically acceptable carrier therefor, in which the composition has an ionic strength of not more than 0.12, in which the amount of the compound of formula (I) is 0.001% (w / v) at 0.005% (w / v), and whose composition does not contain other antimicrobial agents. |
| priorityDate | 2007-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.